SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Walter Morton who wrote (1884)1/29/1999 9:42:00 AM
From: Steve Harmon  Respond to of 2742
 
Annual Meeting. February 23 at the Waldorf.



To: Walter Morton who wrote (1884)2/1/1999 7:51:00 AM
From: Steve Harmon  Respond to of 2742
 
$14,200,000 in cash.
$30,000,000 deal with Pasteur Merieux.
Annual meeting on the 23rd at the Waldorf.



To: Walter Morton who wrote (1884)2/1/1999 8:09:00 AM
From: Steve Harmon  Respond to of 2742
 
Have you noticed what the 1 million share buyback has done for OSTX's stock price since it was initiated?

Was trading in the same price range as CIST a month ago. Now near $2.

Can you imagine where our shares would be trading with that 4 million share buyback i have been advocating for over a year?



To: Walter Morton who wrote (1884)2/3/1999 12:01:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
The 2 managers left at Cistron have made $1,000,000 since the IMNX settlement.

Cistron shareholders have made $0 since the IMNX settlement.

They should write a book...